Peg IFN/Ribavirin
Multicenter comparison of PEG-IFN α2a or α2b plus ribavirin for treatment-naïve HCV patient in Korean population
... which is the strong predictor of SVR in HCV patients [24]. In addition, our subgroup analysis showed that SVR rates were higher in patients who achieved RVR, regardless of HCV genotype. This result indirectly reflects ...
10
Utility of Detection of Telaprevir Resistant Variants for Prediction of Efficacy of Treatment of Hepatitis C Virus Genotype 1 Infection
... to PEG-IFN–ribavi- rin dual therapy (9–11, 15, 17) and telaprevir–PEG-IFN–ribavirin triple therapy ...to IFN and viral sensitivity to NS3/4A protease inhibitors in determining ...
8
Metabolic syndrome in chronic hepatitis C infection: does it still matter in the era of directly acting antiviral therapy?
... to peg-IFN/ribavirin dual therapy, metabolic factors and insulin resistance do not seem to have a significant effect on telaprevir-based treatment ...of peg-IFN, ribavirin and ...
6
s-2003-41630.pdf
... of PEG-IFN alfa-2b plus ribavirin results in early HCV RNA decays in HIV-HCV co-infected patients, followed by viral load increases as the drug concentration and efficacy decline between ...with ...
6
Abstract
... with ribavirin (RBV) [6, ...with IFN−alpha and RBV ...market: PEG−IFN−alpha2b (PEG−INTRON from wanego IFN−α−2b z ribawiryną u pacjentów z ...
10
Original Article Relationship between application time and dosage of ribavirin and its antiviral efficacy on chronic hepatitis C
... of ribavirin and its antiviral ef- ficacy on chronic hepatitis ...with ribavirin, and their hemoglobin (HGB) reduced to 100 g/L after the treatment; they were divided into a group whose dosage was kept ...
6
Predictors of Complete Early Virological Response to Pegylated Interferon and Ribavirin in Egyptian Patients with Chronic Hepatitis C Genotype 4
... and Ribavirin or Peg IFN and Ribavirin, 1331 ...to peg interferon alfa-2a/Ribavirin treatment in HCV genotype 1 patients representative of the general chronic hepatitis C ...
6
Short versus standard treatment with pegylated interferon alfa-2A plus ribavirin in patients with hepatitis C virus genotype 2 or 3: the cleo trial
... with PEG-IFN- a -2a and ribavirin for 16 weeks was lower than that in patients treated for 24 weeks (62% vs ...of ribavirin (800 mg/day) administered during the ACCELERATE study may account ...
6
Peg-interferon Plus Ribavirin Combination Therapy in HCV Mono-infected and HCV/HIV Co-infected Patients in Iran
... with Peg-IFNα and ribavirin among HCV patients with genotype 1 represent a great virological ...of Peg-IFN-alfa-2a plus ribavirin was similar to the 48-week treatment in HCV genotype ...
6
Boceprevir and personalized medicine in hepatitis C virus infection
... to PEG-IFN- α ...and PEG-IFN- α -ribavirin has not been evaluated until now, and only in a few studies of patients with decompensated cir- rhosis, HIV coinfection, or liver ...
13
A meta-analysis that compares the use of either peginterferon-α2a or peginterferon-α2b plus ribavirin for HCV infection
... to PEG-IFN- α 2a plus ribavirin was higher than the other treatment regimen (RR = ...received PEG-IFN- α 2a plus ribavirin (RR = ...
11
Job performance in chronic hepatitis C virus patients treated with pegylated interferon-α2b plus ribavirin: an observational study
... with Peg-IFN and ribavirin, we observed a decrease in work ability, in activities and hobbies that are normally enjoyed, a decreased ability to focus, concentrate or make decisions, an in- crease in ...
10
Interleukin 28B gene non TT allele strongly predicts treatment failure for genotype 1 infected chronic hepatitis C patients with advanced fibrosis: a case control study
... Abbreviations IL: Interleukin; HCV: hepatitis C virus; SNP: Single nucleotide polymorphism; peg-IFN: Pegylated interferon; PR: Pegylated interferon plus ribavirin; AF: Advanced fibrosis;[r] ...
8
Download Download PDF
... The liver plays a major role in hemostasis and it is well known that patients with chronic liver dis- ease show a marked decrease in liver synthesis of coagulation factors as well as inhibitors []. Coagulation indices ...
5
Incidence and cost of treatment emergent comorbid events in insured patients with chronic hepatitis C virus infection: a retrospective cohort study
... Limitations of this study include those common to claims analysis. A commercially insured population may not be representative of the entire US population nor of treatment patterns in other countries. Lack of clinical ...
8
Association of sustained virologic response with reduced progression to liver cirrhosis in elderly patients with chronic hepatitis C
... Patients and methods: This retrospective study enrolled 145 elderly CHC patients (aged $65 years) who were treatment-naïve and were treated with PEG-IFN plus ribavirin for 6 months between January ...
8
Acute Exacerbation of Liver Disease Induced by Pegylated Interferon Alpha2a Treatment for Chronic Hepatitis C
... of Peg-IFN alpha2a in combination with ribavirin in September, ...the Peg-IFN plus ribavirin therapy in February, ...23. Peg-IFN induced acute liver failure is ...
5
SVR Rates of HCV infected population under PEG IFN α/R treatment in Northwest China
... with ribavirin (PEG-IFN- α /R) had been considered to be the most popular and effective therapy in blocking virus replication before 2015 ...of PEG-IFN- α /R, especially in ...
8
The effect of antiviral therapy on hepatitis C virus related thrombocytopenia: a case report
... We report the case of a 51 - year – old Caucasian female who developed a severe, reversible, immune thrombocy- topenia associated with hepatitis C virus infection. We described also our treatment schedule tapering simul- ...
5
Peginterferon alpha based therapy for chronic hepatitis B focusing on HBsAg clearance or seroconversion: a meta analysis of controlled clinical trials
... to PEG-IFNa regimen could not promote the clinical cure in defined course of treatment but brought heavy financial burden to ...with PEG-IFN a and other nucleos(t)ide ana- ...of PEG-IFNa ...
13